Intravenous Buprenorphine Versus Morphine for Severe Pain in the Emergency Department
Status unconfirmed · Phase 2
Conditions studied: Pain
In brief
This study evaluates intravenous (IV) buprenorphine versus IV morphine for the management of severe, acute pain among emergency department (ED) patients. ED patients with severe pain will be randomized in equal proportion to receive IV buprenorphine or IV morphine.
Key facts
- Study ID
- NCT03256487
- Run by
- Alameda Health System
- People needed
- 122
- Starts
- 2017-09-26
- Expected to finish
- 2018-07-01
- Last updated by the study team
- 2017-10-19
Who can join
Age: 18 and older. Sex: any. Healthy volunteers: not accepted.
You may qualify if…
- ED patients with acute pain NRS ≥7 warranting IV opioid analgesia (according to ED provider)
You may not qualify if…
- Patient refusal
- pregnancy
- level 1 trauma patients
- patients deemed critically ill by provider
- patients in custody
- patients on methadone
- Patients who have received or taken any short acting opioid medication in the past 12 hours.
- Patients who have received or taken any long acting opioid medication in the past 24 hours.
Where it is running
- Alameda Health System, Highland Hospital — Oakland, California, United States (enrolling)
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.